Skip to main content Skip to main navigation menu Skip to site footer
Conference Abstract
Published: 2021-06-19

Analysis of the correlation between the degree of liver fibrosis and the severity of depressive symptoms in patients with NAFLD

Bohomolets National Medical University
Bohomolets National Medical University
nafld depression analysis

Abstract

This is a conference abstract from the III Scientific and Practical Conference "Psychosomatic medicine: science and practice". It is dedicated to the analysis of the correlation between the degree of liver tissue damage and the severity of depressive symptoms in patients with nonalcoholic fatty liver disease.

Full-text of the article is available for this locale: Українська.

References

  1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. doi:10.1016/S0140-6736(14)61682-2
  2. Younossi Z, Henry L. Contribution of alcoholic and non-alcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology 2016;150:1778-85. DOI:https://doi.org/10.1053/j.gastro.2016.03.005
  3. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57. doi:10.1002/hep.29367
  4. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388-402. doi:10.1016/j.jhep.2015.11.004
  5. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. doi:10.1002/hep.28431
  6. Satapathy SK, Sanyal AJ. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2015;35(3):221-35. doi:10.1055/s-0035-1562943
  7. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(2):389-97. doi:10.1053/j.gastro.2015.04.043
  8. Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017;65(5):1557-65. doi:10.1002/hep.29085
  9. Ginès P, Graupera I, Lammert F, et al. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol Hepatol. 2016;1(3):256-60. doi:10.1016/S2468-1253(16)30081-4
  10. Lang CA, Conrad S, Garrett L, et al. Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. J Pain Symptom Manage. 2006;31(4):335-44. doi:10.1016/j.jpainsymman.2005.08.016
  11. Potosek J, Curry M, Buss M, Chittenden E. Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med. 2014;17(11):1271-7. doi:10.1089/jpm.2013.0167
  12. Coggins CC, Curtiss CP. Assessment and management of delirium: a focus on hepatic encephalopathy. Palliat Support Care. 2013;11(4):341-52. doi:10.1017/S1478951512000600
  13. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res. 2000;49(5):311-7. doi:10.1016/s0022-3999(00)00155-0

How to Cite

1.
Скурат К, Коваль І. Analysis of the correlation between the degree of liver fibrosis and the severity of depressive symptoms in patients with NAFLD. PMGP [Internet]. 2021Jun.19 [cited 2021Sep.19];6(2):e0602280. Available from: https://e-medjournal.com/index.php/psp/article/view/280